SCHEMBL5168404

SCHEMBL5168404

CC(=O)N(c1c(-c2ccc(OC(=O)O)o2)nc2ccc(C)cn12)C(C)(C)CC(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.35
NPC1 O15118 1/20 0.35
PKM P14618 4/20 0.35
PKLR P30613 3/20 0.35
KDM4E B2RXH2 3/20 0.34
TP53 P04637 3/20 0.34
HPGD P15428 2/20 0.34
HSD17B10 Q99714 2/20 0.34
GABRA1 P14867 2/20 0.34
GABRB2 P47870 2/20 0.34
MAPT P10636 2/20 0.34
LMNA P02545 2/20 0.34
POLB P06746 2/20 0.34
ALB P02768 1/20 0.34
CYP3A4 P08684 1/20 0.34
CHRM1 P11229 1/20 0.34
GABRB1 P18505 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA3 P34903 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5168400 0.86 PKM (0.36) RAB9ANPC1PKMPKLRKDM4E
SCHEMBL5165682 0.83 CREBBP (0.35)
SCHEMBL5169200 0.82
SCHEMBL5167454 0.81 MEN1 (0.37) RAB9ANPC1KDM4ETP53HPGD
SCHEMBL5164549 0.80 GABRA1 (0.50) RAB9ANPC1KDM4ETP53HPGD
SCHEMBL5169251 0.76 GAA (0.40) RAB9ANPC1KDM4ETP53HSD17B10
SCHEMBL5168360 0.73 RAB9A (0.36) RAB9ANPC1PKMKDM4ETP53
SCHEMBL5167458 0.70 PKM (0.38) RAB9ANPC1PKMPKLRKDM4E
SCHEMBL5165500 0.69 KMT2A (0.37) RAB9ANPC1PKMPKLRKDM4E
SCHEMBL5169195 0.68 KDM4E (0.34) RAB9AKDM4EHSD17B10ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1326613-B2 USE OF SUBSTITUTED IMIDAZO 1,2-A|PYRIDINE-, IMIDAZO ¬1,2-A|PYRIMIDINE AND IMIDAZO ¬1,2-A|PYRAZINE-3-YL-AMINE DERIVATIVES FOR PRODUCING NOS-INHIBITING MEDICAMENTS GRUENENTHAL GMBH (DE) 2007-04-18 EP disclosed
EP-1326613-B1 USE OF SUBSTITUTED IMIDAZO 1,2-A]PYRIDINE-, IMIDAZO [1,2-A]PYRIMIDINE AND IMIDAZO [1,2-A]PYRAZINE-3-YL-AMINE DERIVATIVES FOR PRODUCING NOS-INHIBITING MEDICAMENTS GRUENENTHAL GMBH (DE) 2004-06-02 EP disclosed